BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會


Hsin-Hsin Shen

Session 7 – Public Private Partnership for Precision Health

Date:22 July (Thursday)
Time:  12:20 – 13:50 (GMT+8)

Hsin-Hsin Shen

Division Director, Biomedical Technology and Device Research Laboratories,
Industrial Technology Research Institute (ITRI)

Dr. Shen works in the Industrial Technology Research Institute and leads the research and development team focuses on regenerative medicine, tissue engineering, biomedical material for implantable device, and cell therapy technologies. In recent years, her major impacts are supporting and facilitating the industry to establish regenerative medicine product manufacturing process and quality control technology, linking to clinical trials and regulatory verification of the medical center.


Speech title & Synopsis

Industry cross discipline integration strategy for tendon and ligament regeneration

This project applies Taiwan’s fiber/textile industry with tissue engineering technology to conduct into the implantable medical device industry. In order to solve the clinical unmet need, this project has many challenges ahead, including mechanical properties, biocompatibilities, process consistence and scale-up manufactures. To overcome these challenges, we will develop material formulations, fiber processes, textile structures and clinical assessments. We hope that these outcomes will then promote domestic textile and medical device industries, and bring more investment in high-end medical devices to increase values of whole industry.